Skip to content
Recall Observatory FDA recall evidence

Drug product

Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals America, Inc, Deerfield, IL 60015. NDC: 64764-510-30

D-0026-2019

September 10, 2018

Class II

Product summary

Firm
Takeda Development Center Americas, Inc.
Event
Event 80964
Status
Terminated
Classification
Class II
Quantity
7,248 bottles
Official record key
drug-enforcement:D-0026-2019

Official wording

Reason: Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.

Code information: Lot, expiry: A26004, exp Apr 2020; A26443 and A26444, exp Sep 2020

Distribution pattern: AR, LA, MS, NC, NJ, OH, PA, SC and Puerto Rico

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.

Field note

Send feedback

We'll only use this to respond to your feedback.